Advertisement
Screener

NURIX THERAPEUTICS, INC. (NRIX) Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax

NURIX THERAPEUTICS, INC. Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax

NURIX THERAPEUTICS, INC. (NRIX) had Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax of $5.00 thousand as of 2026-05-31, per its 10-Q filed 2026-07-09.

Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2026-07-09

  • 2026-05-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $5.00K.
  • 2026-02-28: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $88.00K.
  • 2025-11-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $115.00K.
  • 2024-11-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $303.00K.
Period endDebt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax
2026-05-31$5.00K
10-Q · filed 2026-07-09
2026-02-28$88.00K
10-Q · filed 2026-04-08
2025-11-30$115.00K
10-Q · filed 2026-07-09
2024-11-30$303.00K
10-K · filed 2026-01-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36